Brief: HLS Therapeutics Announces Normal Course Issuer Bid

HLS Therapeutics

09/05/2018 22:13

May 9 (Reuters) - HLS Therapeutics Inc  HLS.V :
    * HLS THERAPEUTICS ANNOUNCES NORMAL COURSE ISSUER BID
    * HLS THERAPEUTICS - PURSUANT TO NORMAL COURSE ISSUER BID,
CO MAY
PURCHASE FOR CANCELLATION UP TO AGGREGATE OF 1.4 MILLION OF ITS
ISSUED & OUTSTANDING SHARES

Source text for Eikon:  ID:nCNWbd2l7a 
Further company coverage:  HLS.V 

 ((Reuters.Briefs@thomsonreuters.com;))